RYLD vs XBI
Global X Russell 2000 Covered Call ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.60% for RYLD.
- • RYLD pays a higher dividend yield (11.85%).
Side-by-side metrics
| Metric | RYLD | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.60% | 0.35% |
Dividend yield Trailing 12-month yield. | 11.85% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $1.32B | $8.30B |
YTD return | 6.49% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.55 | 1.09 |
P/E ratio | 19.20 | — |
Last price | $15.61 | $133.66 |
Inception | — | — |
Issuer | Global X | State Street |
RYLD top holdings
| RSSL | Global X Russell 2000 ETF | 101.94% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About RYLD
RYLD (Global X Russell 2000 Covered Call ETF) is Russell 2000 covered call strategy for income. Managed by Global X, the fund carries $1.3B in assets under management, an expense ratio of 0.60%, a dividend yield of 11.85%. Its largest holding is Global X Russell 2000 ETF (RSSL), which represents 101.9% of the portfolio. Real Estate is the fund's largest sector exposure at 6.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.